PYGL p.Gln577Ter
c.1729C>T · rs149096315 · VCV632216
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 14 of 20 |
| Splicing | ||
| SpliceAI | Δ0.24 | acceptor loss, 27 bp away · masked 0 · deltas |
| Pangolin | Δ0.22 | loss · gain 0.10 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.9, phastCons 1 |
| Overall | ||
| CADD | 49.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0208% | 4,807 |
| European (non-Finnish)grpmax | 0.0183% | 5,463 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,606 |
| African / African-American | 0.00267% | 37,462 |
| South Asian | 0.0022% | 45,546 |
| Admixed American | 0.00167% | 60,002 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PYGL
- Protein
- p.Gln577Ter
- Coding
- c.1729C>T
- MANE Select
- NM_002863
- dbSNP
- rs149096315
- Type
- single nucleotide variant
- Location
- chr14:50912195 (GRCh38)
- Gene constraint
- LOEUF 1.048 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 92.87 · 19 PDB
- Residue 577
- an α-helix
Disease context
glycogen storage disease VI — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: disorder of glycogen metabolism
For Glycogen storage disease due to liver glycogen phosphorylase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
Similar variants
- PYGL p.Gln577His Uncertain significance ★★ ⚠ same residue
- PYGL c.1404-1G>A Pathogenic/Likely pathogenic ★★ same condition
- PYGL c.1620+1G>A Pathogenic/Likely pathogenic ★★ same condition
- PYGL c.1620+1G>C Pathogenic ★★ same condition
- PYGL c.1768+1G>A Pathogenic ★★ same condition
- PYGL c.772+1G>A Pathogenic/Likely pathogenic ★★ same condition
- PYGL p.Arg576Ter Pathogenic ★★ same condition
- PYGL p.Arg94Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pygl-p-gln577ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown